Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Akaishi, Junko ^a   Onda, Masamitsu ^a   Okamoto, Junichi ^a   Miyamoto, Shizuyo ^a   Nagahama, Mitsuji ^b   Ito, Kouichi ^b   Yoshida, Akira ^c   Shimizu, Kazuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b ITO HOSPITAL   (Japan)

^c KANAGAWA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION ELONGATION FACTOR; TRANSCRIPTION ELONGATION FACTOR A (SII) LIKE 4; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYROID CANCER;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; CARCINOMA; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA, COMPLEMENTARY; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS; ORGAN SPECIFICITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; THYROID GLAND; THYROID NEOPLASMS; TRANSCRIPTIONAL ELONGATION FACTORS;

EID: 33750987321     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-260     Document Type: Article

References (23)

1. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA: Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 1990, 15:321-330.
2. Demeter JG, De Jong SA, Lawrence AM, Paloyan E: Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 1991, 110-956-961.
3. Passler C, Scheuba C, Prager G, Kaserer K, Flores JA, Vierhapper H, Niederle B: Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis. Langenbecks Arch Surg 1999, 384:284-293.
4. Wiseman SM, Loree TR, Rigual NR, Hicks WL Jr, Douglas WG, Anders: Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck 2003, 25:662-670.
5. Hunt JL, Tometsko M, LiVolsi VA, Swalsky P, Finkelstein SD, Barnes EL: Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. Am J Surg Pathol 2003, 27:1559-1564.
6. Onda M, Emi M, Yoshida A, Miyamoto S, Akaishi J, Asaka S, Mizutani K, Shimizu K, Nagahama M, Ito K, Tanaka T, Tsunoda T: Comprehensive Gene Expression Profiling of Anaplastic Thyroid Cancers with cDNA Microarray of 25,344 Genes. Endocr Relat Cancer 2004, 11:843-54.
7. Yeh CH, Shatkin AJ: A HeLa-cell-encoded p21 is homologous to transcription elongation factor SII. Gene 1994, 143:285-287.
8. Yeh, CH, Shatkin AJ: Down-regulation of Rous sarcoma virus long terminal repeat promoter activity by a HeLa cell basic protein. Proc Nat Acad Sci 1994, 91:11002-11006.
9. Pillutia RC, Shimamoto A, Furuichi Y, Shatkin AJ: Genomic structure and chromosomal localization of TCEALI, a human gene encoding the nuclear phosphoprotein p21/SIIR. Genomics 1999, 56:217-220.
10. Onda M, Akaishi J, Asaka S, Okamoto J, Miyamoto S, Mizutani K, Yoshida A. Ito K, Emi M: Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth. Br J Cancer 2005, 20:2216-2224.
11. Ozaki O, Ito K, Mimura T, Sugino K, Ito K: Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: a histologic and immunohistochemical study. J Surg Oncol 1999, 70:45-48.
12. Lam KY, Lo CY, Chan KW, Wan KY: Insular and anaplastic carcinoma of the thyroid. A 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 2000, 231:329-338.
13. Saunders CA, Nayar R: Anaplastic spindle-cell squamous carcinoma arising in association with tall-cell papillary cancer of the thyroid: A potential pitfall. Diagn Cytopathol 1999, 21:413-418. Erratum in: Diagn Cytopathol 2000, 22:136
14. Nakamura T, Yana I, Kobayashi T, Shin E, Karakawa K, Fujita S, Miya A, Mori T, Nishisho I, Takai S: p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas. Jpn J Cancer Res 1992, 83:1293-1298.
15. Moretti F, Farsetti A, Soddu S, Misiti S, Crescenzi M, Filetti S, Andreoli M, Sacchi A, Pontecorvi A: p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Oncogene 1997, 13:729-740.
16. TGarcia-Rostan GT, TTallini GT, THerrero AT, TD'Aquila TGT, TCarcangiu MLT, TRimm DLT: Frequent Mutation and Nuclear Localization of β-Catenin in Anaplastic Thyroid Carcinoma. Cancer Res 1999, 59:1811-1815.
17. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE: BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 2003, 88:5399-5404.
18. Pilotti S, Collini P, Rilke F, Cattoretti G, Del Bo R, Pierotti MA: Bcl2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 1994, 172:337-342.
19. Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, Khan A: The role of cell cycle regulatory protein, cyclin DI, in the progression of thyroid cancer. Mod Pathol 2000, 13:882-887.
20. Ito Y, Yoshida H, Shibahara K, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Uchimi T, Kuwano M, Miyoshi E, Matsuura N, Kuma K, Miyauchi A: Y-box binding protein expression in thyroid neoplasms: its linkage with anaplastic transformation. Pathol Int 2003, 53:429-433.
21. Hayashi N, Nakamori S, Hiraoka N, Tsujie M, Xundi X, Takano T, Amino N, Sakon M, Monden M: Antitumor effects of peroxisome proliferator activate receptor gammma ligands on anaplastic thyroid carcinoma. Int J Oncol 2004, 24:89-95.
22. Ito Y, Yoshida H, Tomoda C, Urano T, Takamura. Y, Miya A, Kobayashi K, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A: Maspin expression is directly associated with biological aggressiveness of thyroid carcinoma. Thyroid 2004, 14:13-18.
23. Kitamura Y, Shimizu K Tanaka S, Ito K, Emi M: Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q. Genes Chromosomes Cancer 2000, 27:244-225.